Sample Appeal Letter Template

ADVERTISEMENT

[Date]  
 
[Payer   n ame]    
ATTN:   A PPEALS  
[Payer   c ontact   n ame]    
[Payer   a
ddress]  
 
Patient:  
[ Patient’s   f irst   a nd   l ast   n
ame]    
Subscriber   I D#:  
[ Insurance   I D   # ]    
Subscriber   G roup   # :  
[ Insurance   g roup   #
]  
Re:   C OTELLIC®   ( cobimetinib)   t ablets  
Dates   o f   S ervice:  
[ Include   a ll   d enied   d ates   o f   s
ervice]    
 
Dear   A ppeals   R eviewer:  
 
I   a m   w riting   t o   r equest  
[
appeal/redetermination/reconsideration]   o f   t he   a bove   d enial(s)   o f  
COTELLIC®   ( cobimetinib)   t ablets   f or   m y   p atient  
[ patient   n
ame].   I   u nderstand   f rom   y our  
denial   l etter   t hat   t he   d enials   w ere   b ased   o n  
[ denial   r
eason].     I   w ould   l ike   t o   a ddress  
[ that  
reason/those   r
easons]   n ow.   I   w ould   a ppreciate   a   p rompt   r eview   o f   t he   e nclosed  
information   d emonstrating   m edical   n ecessity   a nd   c overage   f or   C OTELLIC.      
 
Patient’s   C linical   H istory  
[Patient’s   n
ame]   i s   a  
[
age]   y ear   o ld  
[
male/female]   w ho   w as   d iagnosed   o n  
[
date]   w ith   s tage  
[IIIC/   I
V]   m etastatic   m elanoma.   T reatment   o ptions   f or   p atients   w ith   m etastatic   m elanoma  
are   l
imited.   [
He/She]   u nderwent  
[ describe   t reatment   t o   d
ate].  
 
[Include   d iagnosis   a nd   d ates]  
[Past   t reatments]  
[Test   r esults   t hat   i ndicate   f ailure   o f   p ast   t reatment]  
[Extenuating   c ircumstances   t hat   w ould   p reclude   a lternatives   t o   C OTELLIC]  
[Social   &   f amily   i nformation]  
 
[REMINDER:   I f   a   p ayer   h as   a   p ublished   p olicy,   i nclude   h ere]    
[REMINDER:   I f   s tate   s tatute   e xists,   i nclude   h ere]  
 
Treatment   P lan  
On   1 1/10/2015,   t he   F DA   a pproved   t he   u se   o f   C OTELLIC   f or   t he   t reatment   o f   p atients   w ith  
unresectable   o r   m etastatic   m elanoma   w ith   B RAF   V 600E   o r   V 600K   m utation,   i n   c ombination  
with   v emurafenib.    
 
[Include   p lan   o f   t reatment   ( dosage,   l ength   o f   t reatment),   F DA   A pproval   L etter,   r elevant  
journal   a rticles,   c linical   s tudies,   a nd   c linical   p ractice   g uidelines   t hat   s upport   t he   u se   o f  
COTELLIC.   C onsider   m entioning   e xperts   i n   t he   f ield   w ho   a lso   s upport   t he   t reatment.]  
 
Summary  
In   s ummary,   I   a m   r equesting  
[ appeal/   r edetermination/   r
econsideration]   o f   t he   d enial(s)   o f  
COTELLIC   t herapy   f or   m y   p atient,  
[ Patient   N
ame].  
[ He/   S
he]   w as   d iagnosed   w ith  
unresectable   s tage  
[ IIIC/   I
V]   m elanoma   w hich   i s   p ositive   f or   t he   B RAF   V 600   m utation;   a  
life-­‐threatening   m elanoma   w ith   f ew   t reatment   o ptions.   I   a m   r equesting   t hat   y ou   r econsider  
coverage   b ased   o n   t he   i nformation   a bove.   I   a m   r eadily   a vailable   a t   m y   o ffice   p hone  
[ MD  
ACS/030915/0032

ADVERTISEMENT

00 votes

Related Articles

Related forms

Related Categories

Parent category: Letters
Go
Page of 2